Leukemia, Acute Myeloid (AML)
1 competing product in clinical development for Leukemia, Acute Myeloid (AML).
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| gilteritinib + LoDAC (Low Dose Cytarabine) + Azacitidine + MEC (Mitoxantrone, Etoposide, Cytarabine) + FLAG-IDA (Granulocyte-Colony Stimulating Factor (G-CSF), Fludarabine, Cytarabine, Idarubicin) | Astellas Pharma | Phase 3 | Completed | 40 |